Rhythm Pharmaceuticals, Inc. (RYTM)
87.66
+1.95
(+2.28%)
USD |
NASDAQ |
Jun 11, 16:00
87.66
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Price to Book Value : 48.82 for June 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 47.73 |
| June 09, 2026 | 48.93 |
| June 08, 2026 | 47.85 |
| June 05, 2026 | 48.12 |
| June 04, 2026 | 48.79 |
| June 03, 2026 | 47.17 |
| June 02, 2026 | 46.97 |
| June 01, 2026 | 48.93 |
| May 29, 2026 | 49.18 |
| May 28, 2026 | 51.78 |
| May 27, 2026 | 51.02 |
| May 26, 2026 | 50.13 |
| May 22, 2026 | 49.02 |
| May 21, 2026 | 50.29 |
| May 20, 2026 | 50.54 |
| May 19, 2026 | 48.63 |
| May 18, 2026 | 48.42 |
| May 15, 2026 | 50.47 |
| May 14, 2026 | 52.21 |
| May 13, 2026 | 52.26 |
| May 12, 2026 | 50.91 |
| May 11, 2026 | 48.73 |
| May 08, 2026 | 52.51 |
| May 07, 2026 | 53.66 |
| May 06, 2026 | 53.87 |
| Date | Value |
|---|---|
| May 05, 2026 | 51.47 |
| May 04, 2026 | 47.72 |
| May 01, 2026 | 45.62 |
| April 30, 2026 | 45.36 |
| April 29, 2026 | 45.79 |
| April 28, 2026 | 46.94 |
| April 27, 2026 | 47.51 |
| April 24, 2026 | 47.73 |
| April 23, 2026 | 47.45 |
| April 22, 2026 | 47.43 |
| April 21, 2026 | 47.29 |
| April 20, 2026 | 48.85 |
| April 17, 2026 | 49.39 |
| April 16, 2026 | 49.07 |
| April 15, 2026 | 48.90 |
| April 14, 2026 | 48.61 |
| April 13, 2026 | 48.34 |
| April 10, 2026 | 47.00 |
| April 09, 2026 | 47.96 |
| April 08, 2026 | 47.60 |
| April 07, 2026 | 48.26 |
| April 06, 2026 | 48.43 |
| April 02, 2026 | 48.05 |
| April 01, 2026 | 49.07 |
| March 31, 2026 | 48.43 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.931 |
| Biogen, Inc. | 1.582 |
| Regeneron Pharmaceuticals, Inc. | 2.042 |
| Vertex Pharmaceuticals, Inc. | 5.789 |
| AbbVie, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 26.72 |
| PEG Ratio | -2.440 |
| Price | 87.66 |
| Earnings Yield | -3.58% |
| Market Cap | 6.000B |
| PEGY Ratio | -2.440 |